Evidence map›Paper›PMID 35392258›Full record

ArticleBioMed research international2022

Use of Machine Learning and Routine Laboratory Tests for Diabetes Mellitus Screening.

Glauco Cardozo, Guilherme Brasil Pintarelli, Guilherme Rettore Andreis, Annelise Correa Wengerkievicz Lopes, Jefferson Luiz Brum Marques

Abstract read
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Automated sample annotation for diabetes mellitus in healthcare integrated biobanking.Computational and structural biotechnology journal · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Glauco CardozoAcademic Department of Health and Services, Federal Institute of Santa Catarina, Florianopolis, SC 88020-300, Brazil.ORCID https://orcid.org/0000-0002-3694-6047
Guilherme Brasil PintarelliInstitute of Biomedical Engineering, Federal University of Santa Catarina, Florianopolis, SC 88040-900, Brazil.ORCID https://orcid.org/0000-0002-6920-0049
Guilherme Rettore AndreisInstitute of Biomedical Engineering, Federal University of Santa Catarina, Florianopolis, SC 88040-900, Brazil.ORCID https://orcid.org/0000-0003-2593-331X
Annelise Correa Wengerkievicz LopesSanta Luzia Medical Laboratory, Florianopolis, SC 88.117-001, Brazil.ORCID https://orcid.org/0000-0002-2189-909X
Jefferson Luiz Brum MarquesInstitute of Biomedical Engineering, Federal University of Santa Catarina, Florianopolis, SC 88040-900, Brazil.ORCID https://orcid.org/0000-0001-8910-4735

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most patients with diabetes mellitus are asymptomatic, which leads to delayed and more complex treatment. At the same time, most individuals are routinely subjected to standard clinical laboratory examinations, which create large health datasets over a lifetime. Computer processing has been used to search for health anomalies and predict diseases using clinical examinations. This work studied machine learning models to support the screening of diabetes through routine laboratory tests using data from laboratory tests of 62,496 patients. The classification and regression models used were the K-nearest neighbor, support vector machines, Bayes naïve, random forest models, and artificial neural networks. Glycated hemoglobin, a test used for diabetes diagnosis, was used as the target. Regression models calculated glycated hemoglobin directly and were later classified. The performance of classification computer models has been studied under various subdataset partitions and combinations (e.g., healthy, prediabetic, and diabetes, as well as no healthy and no diabetes). The best single performance was achieved with the artificial neural network model when detecting prediabetes or diabetes. The artificial neural network classification model scored 78.1%, 78.7%, and 78.4% for sensitivity, precision, and F1 scores, respectively, when identifying no healthy group. Other models also had good results, depending on what is desired. Machine learning-based models can predict glycated hemoglobin values from routine laboratory tests and can be used as a screening tool to refer a patient for further testing.

Indexed as

Diabetes MellitusPrediabetic StateBayes TheoremGlycated HemoglobinHumansMachine LearningNeural Networks, ComputerSupport Vector MachineGlycated Hemoglobin

Identifiers

PMID35392258
PMCPMC8983182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.